About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prevention of Severe Postpartum Hypertension

NCT02450773·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Indiana University

Age

Any age

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

Women \> 18 years of age or emancipated minors
Women undergoing vaginal or cesarean delivery at \> 23 weeks gestation with:
Antepartum diagnosis of gestational hypertension
Antepartum diagnosis of preeclampsia
Antepartum diagnosis of preeclampsia with severe features
Mild hypertension (\<150/100) in first 24 hours following delivery

You may not be if

Chronic hypertension
Allergy to furosemide
Pre-existing hypokalemia (serum K \< 3.0 meq/L)
Chronic kidney disease
Serum Cr \> 1.1
Inability to obtain informed consent
Pre-existing diuretic use
Oliguria

The record

StatusWithdrawn

PhasePhase 2

Taking part0

StartedAug 2015

UpdatedMay 11, 2023

Conditions

Where2

Indiana University School of Medicine
Indianapolis, Indiana, United States
Washington University School of Medicine
St Louis, Missouri, United States

Clareo Health | Prevention of Severe Postpartum Hypertension